Insider Transactions last 24 months for Apellis Pharmaceuticals, Inc.  -  NSDQ: APLS

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Dunlop A. SinclairDirector09/19/2025DJIndirectCOM3,837$0.00$0.0065,071
Dunlop A. SinclairDirector09/19/2025DSIndirectCOM31,092$22.95$713,561.4068,908
Watson David O.General Counsel09/16/2025DSDirectCOM5,000$24.34$121,700.00118,730
Chopas James GeorgeVP/Chief Accounting Officer09/15/2025DSDirectCOM189$24.19$4,572.2953,468
Watson David O.General Counsel09/10/2025DSIndirectCOM20,000$26.17$523,400.0050,136
Sullivan Timothy EugeneChief Financial Officer09/08/2025DSIndirectCOM10,000$27.83$278,300.0060,396
Sullivan Timothy EugeneChief Financial Officer09/08/2025DSDirectCOM32,729$27.86$911,829.94110,936
Sullivan Timothy EugeneChief Financial Officer09/08/2025AMDirectCOM15,000$10.03$150,450.00143,665
Boucher KelleyChief People Officer09/02/2025AADirectCOM30,476$0.00$0.0097,658
Chopas James GeorgeVP/Chief Accounting Officer09/02/2025DSDirectCOM548$28.08$15,386.2053,657
Francois CedricChief Executive Officer08/28/2025DSIndirectCOM49,963$28.39$1,418,449.57307,946
Francois CedricChief Executive Officer08/27/2025DSIndirectCOM175,037$28.19$4,934,293.03357,909
Meltzer LeslieChief Research and Development08/26/2025AADirectCOM61,804$0.00$0.0061,804
Watson David O.General Counsel08/18/2025DSDirectCOM5,000$27.80$139,000.00123,730
Francois CedricChief Executive Officer07/17/2025DSDirectCOM19,725$20.21$398,734.96331,605
Francois CedricChief Executive Officer07/17/2025AMDirectCOM8,997$4.31$38,777.07351,330
Watson David O.General Counsel07/16/2025DSDirectCOM5,000$19.55$97,750.00128,730
Francois CedricChief Executive Officer07/15/2025DSDirectCOM1,900$20.09$38,167.96342,333
Francois CedricChief Executive Officer07/15/2025AMDirectCOM800$4.31$3,448.00344,233
Francois CedricChief Executive Officer07/14/2025DSDirectCOM137,465$20.19$2,774,923.48343,433
Francois CedricChief Executive Officer07/14/2025AMDirectCOM65,203$4.31$281,024.93480,898
Chopas James GeorgeVP/Chief Accounting Officer06/18/2025AADirectCOM6,250$0.00$0.0054,205
Watson David O.General Counsel06/16/2025DSDirectCOM5,000$18.77$93,850.00133,730
Boucher KelleyChief People Officer06/09/2025AADirectCOM45,095$0.00$0.0067,182
Boucher KelleyChief People Officer05/28/2025AADirectCOM22,087$0.00$0.0022,087
1   2  3  4  5  6  7  8  9  Next Last  You are at page 1 of 9 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel